Martin Meglasson
2014 - Bellerophon Therapeutics
In 2014, Martin Meglasson earned a total compensation of $652.6K as former Chief Scientific Officer at Bellerophon Therapeutics.
Compensation breakdown
| Bonus | $266,160 |
|---|---|
| Option Awards | $79,246 |
| Salary | $307,154 |
| Total | $652,560 |
Meglasson received $307.2K in salary, accounting for 47% of the total pay in 2014.
Meglasson also received $266.2K in bonus and $79.2K in option awards.
Rankings
In 2014, Martin Meglasson's compensation ranked 9,341st out of 13,032 executives tracked by ExecPay. In other words, Meglasson earned more than 28.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,341 out of 13,032 | 28th |
Division Manufacturing | 3,510 out of 4,965 | 29th |
Major group Chemicals And Allied Products | 1,191 out of 1,690 | 30th |
Industry group Drugs | 943 out of 1,369 | 31st |
Industry Pharmaceutical Preparations | 719 out of 1,042 | 31st |
Source: SEC filing on April 27, 2016.
Meglasson's colleagues
We found two more compensation records of executives who worked with Martin Meglasson at Bellerophon Therapeutics in 2014.